Tizanidine Tablet
Product Images NDC 80425-0500

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 2mg #30 (Tizanidine 2mg 80425 0500 01)

Label for Tizanidine 2 mg oral tablets by Advanced Rx of Tennessee, LLC. The label includes the NDC 80425-0500-01 with lot and expiration date fields (expires 12/31/2026). It advises storage at 20°-25°C and features a barcode, the statement "Rx Only," and a comparison to Zanaflox.*

FDA Label Image

Tizanidine 2mg #60 (Tizanidine 2mg 80425 0500 02)

Label for tizanidine 2 mg tablets manufactured by Advanced Rx of Tennessee, LLC, Nashville, TN. It includes storage instructions (20°-25°C), a federal transfer caution, and references a comparison to Zanaflex. The label shows the product NDC 80425-0500-02, lot number placeholder, and expiration date 12/31/2026. The package contains 60 tablets and is for Rx only.*

FDA Label Image

Tizanidine 2mg #90 (Tizanidine 2mg 80425 0500 03)

Tizanidine 2 mg tablet packaging label, distributed by Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes a comparison to Zanaflex and states the NDC 80425-0500-03. It also contains storage instructions (20-25°C), lot number, expiration date (12/31/2026), and a caution about federal transfer restrictions. The label indicates the product is for prescription use only.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

Chemical structure of tizanidine hydrochloride, showing its molecular framework with chlorine, nitrogen, sulfur, and hydrogen atoms evident in the diagram.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

A line graph depicting plasma tizanidine concentration (ng/mL) over 24 hours from dosing. The graph compares four conditions: 2x 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food. The x-axis represents hours from dosing, and the y-axis shows plasma concentration, illustrating concentration changes and peak timing under each condition.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

Line graph showing improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis indicates improvement scores, and the x-axis shows hours post-dose. Data points include error bars for variability.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

A line graph comparing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). It shows two groups: tizanidine (mean dose 28.8 mg) with marked improvement and placebo with minimal change. Error bars represent variability at each point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.